Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • HeidiJTP
    Member
    • Nov 2011
    • 22

    #1

    Variant found in priming site

    I sequenced barcoded PCR amplicons on Ion Torrent PGM, and a subset of samples were also Sanger sequenced to confirm variable sites.

    I first noticed that a variant was showing up in the forward priming sequence for one locus in some of the Sanger data and thought it was just a sequencing artefact since the site is not variable in any of my Ion Torrent reads for those same samples.

    However, I found the same issue in the reverse priming sequence for both Sanger and Ion Torrent reads at another locus. The variant does not occur in all of the Ion Torrent reads but it is at the same site as in the Sanger reads. Could this still be an artefact? Am I correct in thinking that a true variant could not be recovered when it occurs within the PCR primer binding site?
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Originally posted by HeidiJTP View Post
    Am I correct in thinking that a true variant could not be recovered when it occurs within the PCR primer binding site?
    Short answer yes, a well known problem with amplicon approaches. Although 'could not' might be better phrased as 'may not'. Depends where it is in the binding site. However I have certainly run across this issue.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...